Skip to search formSkip to main contentSkip to account menu

Nucleoside Reverse Transcriptase Inhibitor

Known as: NRTI, Nucleoside Analog Reverse Transcriptase Inhibitor 
A substance with a structure similar to a nucleoside molecule that is capable of occupying the active catalytic site of a reverse transcriptase… 
National Institutes of Health

Related topics

Related topics

1 relation
Nucleoside Reverse Transcriptase Inhibitors [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.
OBJECTIVES The surveillance of HIV-transmitted drug resistance mutations (t-DRMs), including temporal trends across subtypes and… 
Review
2012
Review
2012
A Tolerability Review of Non-Nucleoside Reverse Transcriptase Inhibitors: Focus on Laboratory Measures of Clinical Relevance
Background: Current antiretroviral (ARV) therapies have greatly extended the life expectancy for many living with HIV infection… 
2007
2007
Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial.
2005
2005
The effect of rosiglitazone on PPARg expression in human adipose tissue Is limited by continued exposure to thymidine NRTI
The Effect of Rosiglitazone on PPARγ Expression in Human Adipose Tissue Is Limited by Continued Exposure to Thymidine NRTI… 
2004
2004
Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failures
No significant changes in viral load and CD4 cell count were observed 2-4 weeks after the withdrawal of non-nucleoside reverse… 
2003
2003
Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trizivir versus continued…
Forty patients participating in the TRIZAL study were treated with a non-nucleoside reverse transcriptase inhibitor (NNRTI… 
2002
2002
Dietary supplements in the treatment of nucleoside reverse transcriptase inhibitor-related mitochondrial toxicity.
2001
2001
Evidence for prolonged clinical benefit from initial combination antiretroviral therapy: Delta extended follow‐up
Background The findings from therapeutic trials in HIV infection with surrogate endpoints based on laboratory markers are only… 
1999
1999
Calanolide A: a natural non-nucleoside reverse transcriptase inhibitor.
Calanolide A, an experimental non-nucleoside reverse transcriptase inhibitor, is a synthetic version of a compound found in… 
1995
1995
New non-nucleoside reverse transcriptase inhibitor.
A new class of drugs called non-nucleoside reverse transcriptase inhibitors are entering phase I clinical trials according to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)